Bapineuzumab

Bapineuzumab is an anti-β-amyloid protein (APP) monoclonal antibody. Bapineuzumab can be used for the research of Alzheimer’s disease (AD)[1].

Amyloid-β

Inhibitory Antibodies

Neuronal Signaling

Neuroscience-Neurodegeneration

Neurological Disease

https://www.medchemexpress.com/bapineuzumab.html

96.62

10 mM in DMSO

[Bapineuzumab]

[1]Stephen Salloway, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med. 2014 Jan 23;370(4):322-33.

Dry Ice

Store at -80°C for 2 years

http://file.medchemexpress.com/batch_PDF/HY-P99185/Bapineuzumab-DataSheet-MedChemExpress.pdf

http://file.medchemexpress.com/batch_PDF/HY-P99185/Bapineuzumab-SDS-MedChemExpress.pdf

Phase 3

648895-38-9